PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Naina Mohamed Pakkir Maideen

Dubai Health Authority

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews1 Guidelines1

Latest

Everything in the corpus, newest first.

SEP 2, 2026 · REVIEW

SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review

Cardiovascular & Haematological Disorders - Drug Targets

This is a narrative review synthesizing clinical trial evidence and guideline recommendations on two drug classes for metabolic syndrome in type 2 diabetes, without presenting original data or a systematic meta-analytic synthesis.

Expert GuidanceCancer Research and Treatment Sulthan Al Rashid Rajkapoor Balasubramanian

Study details

DesignNarrative review of clinical trials, meta-a…

InterventionSGLT-2 inhibitors and GLP-1 receptor agonis…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support